Cwm LLC Has $264,000 Holdings in Haleon plc (NYSE:HLN)

Cwm LLC increased its holdings in Haleon plc (NYSE:HLN) by 13.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,978 shares of the company’s stock after acquiring an additional 2,996 shares during the period. Cwm LLC’s holdings in Haleon were worth $264,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in HLN. Clearbridge Investments LLC grew its position in Haleon by 44.6% in the 1st quarter. Clearbridge Investments LLC now owns 38,446,978 shares of the company’s stock worth $326,415,000 after purchasing an additional 11,865,076 shares in the last quarter. Martin Investment Management LLC grew its position in Haleon by 12,018.4% in the 1st quarter. Martin Investment Management LLC now owns 4,463,205 shares of the company’s stock worth $37,893,000 after purchasing an additional 4,426,375 shares in the last quarter. Sculptor Capital LP grew its position in Haleon by 67.8% in the 2nd quarter. Sculptor Capital LP now owns 8,887,098 shares of the company’s stock worth $73,407,000 after purchasing an additional 3,592,000 shares in the last quarter. The Manufacturers Life Insurance Company grew its position in Haleon by 95.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,954,304 shares of the company’s stock worth $16,143,000 after purchasing an additional 954,622 shares in the last quarter. Finally, Van ECK Associates Corp grew its position in Haleon by 30.7% in the 1st quarter. Van ECK Associates Corp now owns 2,971,084 shares of the company’s stock worth $25,225,000 after purchasing an additional 698,254 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Berenberg Bank started coverage on shares of Haleon in a research report on Tuesday, August 6th. They issued a “buy” rating for the company. UBS Group raised shares of Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. The Goldman Sachs Group downgraded shares of Haleon from a “buy” rating to a “neutral” rating in a research report on Tuesday, August 6th. Finally, Morgan Stanley increased their target price on shares of Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a research report on Friday, September 20th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $10.95.

Haleon Stock Down 0.7 %

Haleon stock opened at $9.91 on Wednesday. The company has a market capitalization of $45.25 billion, a P/E ratio of 33.03, a P/E/G ratio of 2.93 and a beta of 0.26. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The firm has a 50 day moving average price of $10.23 and a 200-day moving average price of $9.17. Haleon plc has a twelve month low of $7.70 and a twelve month high of $10.80.

Haleon (NYSE:HLN) last announced its quarterly earnings results on Thursday, August 1st. The company reported $0.08 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). The business had revenue of $3.50 billion for the quarter, compared to analysts’ expectations of $3.55 billion. Haleon had a net margin of 9.71% and a return on equity of 13.15%. During the same quarter in the previous year, the company posted $0.08 earnings per share. As a group, equities analysts predict that Haleon plc will post 0.47 EPS for the current year.

Haleon Cuts Dividend

The firm also recently declared a semi-annual dividend, which was paid on Thursday, September 19th. Investors of record on Friday, August 16th were paid a dividend of $0.0514 per share. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend was Friday, August 16th. Haleon’s payout ratio is currently 33.33%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.